Suppr超能文献

脑缺血后小鼠大脑中 miR-181b 的下调通过靶向热休克蛋白 A5 和泛素羧基末端水解酶同工酶 L1 诱导对缺血性损伤的神经保护作用。

Downregulation of miR-181b in mouse brain following ischemic stroke induces neuroprotection against ischemic injury through targeting heat shock protein A5 and ubiquitin carboxyl-terminal hydrolase isozyme L1.

机构信息

Department of Neurobiology and Beijing Institute for Brain Disorders, Capital Medical University, Beijing, People's Republic of China; Department of Physiology, School of Medicine, Shanxi Datong University, Datong, People's Republic of China.

出版信息

J Neurosci Res. 2013 Oct;91(10):1349-62. doi: 10.1002/jnr.23255. Epub 2013 Jul 30.

Abstract

Understanding the molecular mechanism of cerebral hypoxic preconditioning (HPC)-induced endogenous neuroprotection may provide potential therapeutic targets for ischemic stroke. By using bioinformatics analysis, we found that miR-181b, one of 19 differentially expressed miRNAs, may target aconitate hydratase (ACO2), heat shock protein A5 (HSPA5), and ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1) among 26 changed protein kinase C isoform-specific interacting proteins in HPC mouse brain. In this study, the role of miR-181b in oxygen-glucose deprivation (OGD)-induced N2A cell ischemic injury in vitro and mouse middle cerebral artery occlusion (MCAO)-induced cerebral ischemic injury in vivo, and its regulation of ACO2, HSPA5, and UCHL1 were further determined. We found that miR-181b expression levels significantly decreased in mouse brain following MCAO and in OGD-treated N2A cells. Up- and downregulation of miR-181b by transfection of pre- or anti-miR-181b could negatively regulate HSPA5 and UCHL1 (but not ACO2) protein levels as well as N2A cell death and programmed cell death in OGD-treated N2A cells. By using a T7 promoter-driven control dual luciferase assay, we confirmed that miR-181b could bind to the 3'-untranslated rergions of HSPA5 and UCHL1 mRNAs and repress their translations. miR-181b antagomir reduced caspase-3 cleavage and neural cell loss in cerebral ischemic cortex and improved neurological deficit of mice after MCAO. In addition, HSPA5 and UCHL1 short interfering RNAs (siRNAs) blocked anti-miR-181b-mediated neuroprotection against OGD-induced N2A cell injury in vitro. These results suggest that the downregulated miR-181b induces neuroprotection against ischemic injury through negatively regulating HSPA5 and UCHL1 protein levels, providing a potential therapeutic target for ischemic stroke.

摘要

了解脑缺氧预处理 (HPC) 诱导内源性神经保护的分子机制可能为缺血性中风提供潜在的治疗靶点。通过生物信息学分析,我们发现 miR-181b 可能是 HPC 小鼠脑中 26 种改变的蛋白激酶 C 同工型特异性相互作用蛋白中 19 种差异表达 miRNA 之一,靶向顺乌头酸水合酶 (ACO2)、热休克蛋白 A5 (HSPA5) 和泛素羧基末端水解酶同工酶 L1 (UCHL1)。在这项研究中,进一步确定了 miR-181b 在体外氧葡萄糖剥夺 (OGD) 诱导的 N2A 细胞缺血性损伤和体内小鼠大脑中动脉闭塞 (MCAO) 诱导的脑缺血性损伤中的作用,及其对 ACO2、HSPA5 和 UCHL1 的调节作用。我们发现,MCAO 后小鼠脑组织和 OGD 处理的 N2A 细胞中 miR-181b 的表达水平显著降低。通过转染 pre-或 anti-miR-181b 上调和下调 miR-181b 可负调控 HSPA5 和 UCHL1(而非 ACO2)蛋白水平以及 OGD 处理的 N2A 细胞中的细胞死亡和程序性细胞死亡。通过使用 T7 启动子驱动的对照双荧光素酶测定,我们证实 miR-181b 可以与 HSPA5 和 UCHL1 mRNA 的 3'-UTR 结合并抑制它们的翻译。miR-181b 拮抗剂减少了大脑缺血皮质中的 caspase-3 切割和神经细胞丢失,并改善了 MCAO 后小鼠的神经功能缺损。此外,HSPA5 和 UCHL1 短发夹 RNA (siRNA) 阻断了抗 miR-181b 介导的体外对 OGD 诱导的 N2A 细胞损伤的神经保护作用。这些结果表明,下调的 miR-181b 通过负调控 HSPA5 和 UCHL1 蛋白水平诱导对缺血性损伤的神经保护作用,为缺血性中风提供了一个潜在的治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验